HIV Treatment: ALERTS! articles from June 1 2007

HIV Treatment: ALERTS! archives from June 1 2007

The 14th Conference on Retroviruses and Opportunistic Infections (CROI): Los Angeles, February 25th-28th.(HIGHLIGHTS)
June 1, 2007... The 14th Conference on Retroviruses and Opportunistic Infections (CROI), held in Los Angeles from February 25th to the 28th, is one of the biggest HIV science conferences held each year. As in past years, the world's leading researchers...

New drug profile: Maraviroc: it's different, it's strong, and it's almost here.(Drug overview)
June 1, 2007... What is it? Maraviroc (or Celsentri) is an HIV medication, the first of its kind. Maraviroc doesn't block HIV directly; instead, maraviroc binds to a human protein known as CCR5. This is one of the proteins HIV uses to enter human T cells....

HIV super strain revisited.(IN THE NEWS)
June 1, 2007... In the April 2005 edition of The Center for AIDS Information & Advocacy HIV Treatment ALERTS! we reported the strange case of a 40-something year old, gay man in New York City (referred to as NYC) who appeared to be newly infected with a form...

Green tea: fact or fiction.(treatment news)
June 1, 2007... Scientists have discovered that a substance in green tea prevents HIV from attaching to our immune system cells by getting there first. According to researchers from Baylor College of Medicine in Houston and the University of Sheffield in the...

Fuzeon update.(Brief article)
June 1, 2007... In January, new precautions were added to the labeling for the injectable HIV fusion inhibitor Fuzeon. The new information focuses on side effects reported when the Biojector 2000 needle-free device is used to inject Fuzeon. In addition, the...

Sustiva drug interactions.(FDA BITS)
June 1, 2007... In January, new precautions were added to the labeling for the "non-nuke" Sustiva concerning potential drug interactions. Patients taking Sustiva should not take Hismanal (astemizole), Vascor (bepridil), Propulsid (cisapride), Versed...

Anemia treatment warnings.(treatment news)
June 1, 2007... In March, the Food and Drug Administration (FDA) issued a warning about the use of Aranesp, Epogen, and Procrit in all patients. These drugs are called erythropoiesis-stimulating agents (ESAs). They stimulate a patient's bone marrow to produce...

Radiesse approved.(treatment news)
June 1, 2007... Last December, the Food and Drug Administration (FDA) approved Radiesse, an injectable filler to correct signs of facial lipoatrophy (loss of fat) in HIV+ people. Until now, Sculptra was the only facial filler approved by the FDA for this...

Definitions.
June 1, 2007... Anemia: low levels of red blood cells or hemoglobin in the blood, resulting in feelings of tiredness or fatigue. Antibody: proteins produced by the immune system to fight specific bacteria, viruses, or other antigens. Chemokine...